NORTHLEAF CAPITAL PARTNERS

Thesis

Northleaf Capital Partners is a global private markets investment firm with a focus on mid-market companies and assets across private equity, private credit, and infrastructure. Their strategy involves rigorous selectivity, global sourcing, and active portfolio construction to achieve risk-adjusted returns less correlated with public markets. In private equity, they engage in buyouts, growth equity, and venture capital through primary funds, direct co-investments, structured capital, and secondary transactions. Their venture capital and growth equity focus is on primary funds and late/growth-stage direct investments in technology and healthcare. For private credit, they offer floating-rate loans and financing to mid-market borrowers, including corporate direct lending and asset-based specialty finance. Infrastructure investments target control stakes in mid-market assets with long-term cash flows, with a current emphasis on sustainable infrastructure and the energy transition. Northleaf operates globally with offices in North America, the UK/Europe, Asia, and Australia, leveraging deep mid-market expertise. As of May 2025, they had raised over $28 billion in commitments. The firm was founded in 2009 following a spin-out from TD Bank.

Related lists

• Series C+ Developer Tools investors
• Series C+ Healthcare investors